Text Size

Atherosclerosis Risk in Communities (ARIC)

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005131
First received: May 25, 2000
Last updated: April 13, 2009
Last verified: April 2009
History of Changes
  Purpose

To measure associations of established and suspected coronary heart disease risk factors with both atherosclerosis and new coronary heart disease events in representative cohorts from four diverse United States communities. To compare the communities with respect to risk factors, medical care, atherosclerosis, and coronary heart disease incidence. ARIC has two components in each community: study of representative cohorts of adult men and women, and community surveillance of morbidity and mortality.


Condition
Atherosclerosis
Coronary Disease
Coronary Heart Disease Risk Reduction
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Heart Failure, Congestive
Heart Failure

Study Type: Observational

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: July 1985
Study Completion Date: January 2007
Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

No eligibility criteria

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00005131

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Investigator: Christie Ballantyne Baylor College of Medicine
Investigator: Lloyd Chambless University of North Carolina
Investigator: Josef Coresh Johns Hopkins University
Investigator: Matthew Davis University of Wisconsin, Madison
Investigator: Aaron Folsom University of Minnesota - Clinical and Translational Science Institute
Investigator: Gerardo Heiss University of North Carolina
Investigator: Daniel Jones University of Mississippi Medical Center
Investigator: Kenneth Wu Texas Health Science Center
  More Information

Additional Information:
Related Info  This link exits the ClinicalTrials.gov site

No publications provided by National Heart, Lung, and Blood Institute (NHLBI)

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT00005131     History of Changes
Other Study ID Numbers: 1001
Study First Received: May 25, 2000
Last Updated: April 13, 2009
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Atherosclerosis
Cardiovascular Diseases
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Diabetes Mellitus
Heart Diseases
 Heart Failure
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 19, 2013